Rejunuron DN Tablet SR
By Rejunuron DN
Rx
10 Tablet SR in a Strip

Composition
Methylcobalamin(1500mcg) + Pregabalin(75mg)

Manufacturer - Fourrts India Laboratories Pvt Ltd
#1, Fourrts Avenue, Annai Indira Nagar, Okkiyam Thoraipakkam, Chennai, India

Expires on or after
February, 2027

liver
Rejunuron DN Tablet SR is considered safe for individuals with liver disease based on the available data. It appears that adjusting the dose of Rejunuron DN Tablet SR may not be necessary for these patients. However, it is always recommended to consult with your doctor before starting any medication, especially if you have liver issues. Your doctor will be able to provide personalized guidance and ensure that Rejunuron DN Tablet SR is suitable for you.

kidney
Use Rejunuron DN Tablet SR carefully if you have kidney disease. Your doctor may need to adjust the dose. Always seek advice from your healthcare provider.

alcohol
Taking Rejunuron DN Tablet SR with alcohol can make you very sleepy.

driving
Rejunuron DN Tablet SR can reduce alertness and cause drowsiness. Avoid driving if you experience these effects, as they may impair your ability to focus and react quickly.

pregnancy
It is advised to avoid using Rejunuron DN Tablet SR during pregnancy as it may cause harm to the developing baby based on animal studies. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor prior to use.

breastfeeding
Rejunuron DN Tablet SR may not be safe to use during breastfeeding. Limited data indicates the drug might pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹212
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024